医薬 市場調査レポート

このリストでは医薬市場に関する調査レポートを新刊順に紹介しています。
例えば、薬学的薬物、生化学的薬物、バイオ薬物、抗感染性薬物といった分野の動向に関する調査レポート (技術動向、市場規模予測)を紹介しています。又、調剤薬、診断薬、公衆衛生用薬、治療を主目的としない薬物に関する調査レポートも紹介しています。

子癇前症 (循環器) - 開発段階の治療薬　2021年

Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021SummaryPre-Eclampsia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pre-Eclampsia pipeline landscape.The report provides comprehensive information on the therapeutics un…

このレポートの詳細ページはこちら

再発性慢性リンパ球性白血病 (CLL) (腫瘍学) - 開発段階の治療薬　2021年

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021SummaryRelapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline …

このレポートの詳細ページはこちら

再発性多形性膠芽腫 (GBM) (腫瘍学) - 開発段階の治療薬　2021年

Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021SummaryRecurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.Th…

このレポートの詳細ページはこちら

再発急性骨髄性白血病 (腫瘍学) - 開発段階の治療薬　2021年

Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021SummaryRelapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.The report provides compre…

このレポートの詳細ページはこちら

高悪性度神経膠腫 (腫瘍学) - 開発段階の治療薬　2021年

High-Grade Glioma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

High-Grade Glioma (Oncology) - Drugs in Development, 2021SummaryHigh-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the High-Grade Glioma pipeline landscape.The report provides comprehensive information on the therapeutics un…

このレポートの詳細ページはこちら

高トリグリセリド血症 (循環器) - 開発段階の治療薬　2021年

Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021SummaryHypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Hypertriglyceridemia pipeline landscape.The report provides comprehensive information o…

このレポートの詳細ページはこちら

甲状腺乳頭がん (腫瘍学) - 開発段階の治療薬　2021年

Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Papillary Thyroid Cancer (Oncology) - Drugs in Development, 2021SummaryPapillary Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Papillary Thyroid Cancer pipeline landscape.The report provides comprehensive information o…

このレポートの詳細ページはこちら

筋層非浸潤性膀胱がん (NMIBC) (表在性膀胱がん) (腫瘍学) - 開発段階の治療薬　2021年

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021SummaryNon Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 provides an overview of t…

このレポートの詳細ページはこちら

筋層浸潤性膀胱がん (MIBC) (腫瘍学) - 開発段階の治療薬　2021年

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Muscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021SummaryMuscle Invasive Bladder Cancer (MIBC) (Oncology) - Drugs in Development, 2021 provides an overview of the Muscle Invasive Bladder Cancer (MIBC) pipeline landscape.The repo…

このレポートの詳細ページはこちら

胸腺がん (腫瘍学) - 開発段階の治療薬　2021年

Thymic Carcinoma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Thymic Carcinoma (Oncology) - Drugs in Development, 2021SummaryThymic Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Thymic Carcinoma pipeline landscape.The report provides comprehensive information on the therapeutics under…

このレポートの詳細ページはこちら

急性肺障害 (呼吸器) - 開発段階の治療薬　2021年

Acute Lung Injury (Respiratory) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Lung Injury (Respiratory) - Drugs in Development, 2021SummaryAcute Lung Injury (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Lung Injury pipeline landscape.The report provides comprehensive information on the therapeut…

このレポートの詳細ページはこちら

急性心不全 (循環器) - 開発段階の治療薬　2021年

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021SummaryAcute Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Heart Failure pipeline landscape.The report provides comprehensive information on t…

このレポートの詳細ページはこちら

急性虚血性脳卒中 (中枢神経系) - 開発段階の治療薬　2021年

Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021SummaryAcute Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Acute Ischemic Stroke pipeline landscape.The report provides comprehe…

このレポートの詳細ページはこちら

急性感音性難聴 (耳鼻咽喉科疾患) - 開発段階の治療薬　2021年

Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021SummaryAcute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Acute Sensorineural Hearing Loss pipeline…

このレポートの詳細ページはこちら

急性冠症候群 (循環器) - 開発段階の治療薬　2021年

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Acute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021SummaryAcute Coronary Syndrome (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Coronary Syndrome pipeline landscape.The report provides comprehensive info…

このレポートの詳細ページはこちら

肝臓がん (腫瘍学) - 開発段階の治療薬　2021年

Liver Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Liver Cancer (Oncology) - Drugs in Development, 2021SummaryLiver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Liver Cancer pipeline landscape.The report provides comprehensive information on the therapeutics under development…

このレポートの詳細ページはこちら

肝外胆管がん (腫瘍学) - 開発段階の治療薬　2021年

Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Extrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021SummaryExtrahepatic Bile Duct Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Extrahepatic Bile Duct Cancer pipeline landscape.The report provides comprehensiv…

このレポートの詳細ページはこちら

冠動脈疾患 (CAD) （虚血性心疾患） (循環器) - 開発段階の治療薬　2021年

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021SummaryCoronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Coronary Artery Dis…

このレポートの詳細ページはこちら

外陰がん (腫瘍学) - 開発段階の治療薬　2021年

Vulvar Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Vulvar Cancer (Oncology) - Drugs in Development, 2021SummaryVulvar Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Vulvar Cancer pipeline landscape.The report provides comprehensive information on the therapeutics under developm…

このレポートの詳細ページはこちら

化学療法誘発骨髄抑制 (腫瘍学) - 開発段階の治療薬　2021年

Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021SummaryChemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021 provides an overview of the Chemotherapy Induced Myelosuppression pipeline landscape.The repo…

このレポートの詳細ページはこちら